135 filings
8-K
ISEE
IVERIC bio Inc
11 Jul 23
Termination of a Material Definitive Agreement
9:22am
8-K
ISEE
IVERIC bio Inc
6 Jul 23
Submission of Matters to a Vote of Security Holders
1:00pm
8-K
ISEE
IVERIC bio Inc
23 May 23
Departure of Directors or Certain Officers
4:31pm
8-K
ISEE
IVERIC bio Inc
1 May 23
Astellas Enters into Definitive Agreement
7:02am
8-K
ISEE
IVERIC bio Inc
20 Mar 23
Entry into a Material Definitive Agreement
5:16pm
8-K
u0v06ncl
10 Mar 23
Other Events
12:22pm
8-K
yrd9ikyrextq2fgk
1 Mar 23
Iveric Bio Reports Fourth Quarter and Full Year 2022 Operational Highlights and Financial Results
6:43am
8-K
65qb0le2kj
6 Jan 23
Results of Operations and Financial Condition
4:06pm
8-K
yug2fnpu7gjdpgr
27 Dec 22
Entry into a Material Definitive Agreement
4:01pm
8-K
5ymg6m0i0 m7unka5e
12 Dec 22
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
5:04pm
8-K
97slug
5 Dec 22
Iveric Bio Announces Pricing of $300 Million Public Offering of Common Stock
7:45am
8-K
mhxq3xqrl2d8g ax
28 Nov 22
Other Events
8:02am
8-K
0zr1he5ev216v9r3l
17 Nov 22
Other Events
5:16pm
8-K
ku6xj3jvj
3 Nov 22
Iveric Bio Reports Third Quarter 2022 Operational Highlights and Financial Results
6:34am
8-K
g9bd0 lwa51hf
28 Sep 22
Regulation FD Disclosure
4:04pm
8-K
ty17 9njj8eadcdj7cu
7 Sep 22
Other Events
5:30pm
8-K
71ikxprr4 1ogpf
6 Sep 22
Iveric Bio Announces Positive Topline Data from Zimura GATHER2 Phase 3 Clinical Trial in Geographic Atrophy
6:11am
8-K
q85g3rqgh s6
26 Jul 22
Iveric Bio Reports Second Quarter 2022 Operational Highlights and Financial Results
6:36am
8-K
hxtqctkrt3
5 Jul 22
Entry into a Material Definitive Agreement
7:36am
8-K
9tg6di7s5twx
18 May 22
Submission of Matters to a Vote of Security Holders
4:24pm